Redirecting to deep profile of Punit Srivastava at Mediception Science Pvt Ltd...
Click here to continueBelow are the verified contact details to help you connect directly:
Email: pun*****@med******.com
Mobile: 78711*****
Estimated Net Worth: ₹0 – ₹500+ Cr (approx. $0 – $60M)
- Punit Srivastava co-founded MediCeption Science Pvt Ltd in January 2018, contributing to the establishment of a company focused on clinical, regulatory, and medical research.
- As the Chief Scientific Officer (CSO) at MediCeption from January 2016, Punit Srivastava played a critical role in advancing the company's research initiatives and regulatory strategies.
- In August 2018, Punit transitioned to the role of Director of Clinical, Regulatory & Medical Research, further enhancing the organization's ability to navigate complex regulatory environments.
- Prior to founding MediCeption, Punit held the position of Assistant Director at Daiichi Sankyo, Inc. from July 2010 to December 2016, where key achievements included leadership in project management and cross-functional team collaboration.
- Punit's earlier career included a significant tenure as Group Leader at Ranbaxy Research Laboratories from October 2004 to June 2010, where pivotal contributions were made towards the development of innovative pharmaceutical solutions.
- As a Senior Research Fellow at the University of Connecticut from April 2002 to August 2004, Punit advanced expertise in medical research methodologies and clinical trials.
- Punit Srivastava has been instrumental in driving MediCeption’s mission to bridge the gap between innovative science and regulatory compliance, ensuring the company’s projects align with industry standards.
- Throughout the career, Punit has faced challenges such as navigating complex regulatory frameworks and leading diverse research teams, demonstrating resilience and adaptability.